Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis

Abstract

URL: http://www.clinicaltrials.gov. Unique identifier: NCT00940862.